Next Article in Journal
Correction: Xu et al. Use of Optical Redox Imaging to Quantify Alveolar Macrophage Redox State in Infants: Proof of Concept Experiments in a Murine Model and Human Tracheal Aspirates Samples. Antioxidants 2024, 13, 546
Previous Article in Journal
Association Between NOX2-Mediated Oxidative Stress, Low-Grade Endotoxemia, Hypoalbuminemia, and Clotting Activation in COVID-19
Previous Article in Special Issue
An AlphaFold Structure Analysis of COQ2 as Key a Component of the Coenzyme Q Synthesis Complex
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

The Ubiquitous and Multifaceted Coenzyme Q

1
Department of Life and Environmental Sciences (DISVA), Marche Polytechnic University, 60131 Ancona, Italy
2
Centro Andaluz de Biología del Desarrollo, Universidad Pablo de Olavide-CSIC-JA, 41013 Sevilla, Spain
3
CIBERER, Instituto de Salud Carlos III, 28029 Madrid, Spain
*
Authors to whom correspondence should be addressed.
Antioxidants 2024, 13(10), 1261; https://doi.org/10.3390/antiox13101261
Submission received: 10 October 2024 / Accepted: 16 October 2024 / Published: 17 October 2024
(This article belongs to the Special Issue The Ubiquitous and Multifaceted Coenzyme Q)
Coenzyme Q10 (CoQ10) is composed of a benzoquinone ring and an isoprenoid side chain attached to carbon 3 of the ring. The isoprenoid chain is species-specific, e.g., six isoprene units are present in Saccharomyces cerevisiae, CoQ6, and 10 isoprene units in humans, CoQ10. CoQ is present in all species and its basic structure is conserved. Until now, no natural or artificial molecule has been able to replace CoQ10 functions. CoQ10 has been proposed to be an essential component in respiratory-active respirasome and other supercomplexes of the electron transfer chain (ETC) [1]. Supercomplexes modulate the organization of the ETC according to the cellular metabolic requirements, contribute to respiratory efficiency, and limit reactive oxygen species (ROS) production partially through the prevention of ubiquinol accumulation in the respiratory chain [2,3].
The reduction of CoQ10 located in the ETC is also an obligatory step of different pathways essential for cellular homeostasis [4]. Recently, it has been shown that tumor growth depends on the ETC complex III oxidation of ubiquinol (CoQ10H2) [5]. To further understand the role of CoQ10 in cancer progression, it has been demonstrated that CoQ10 and UBIAD1, an enzyme involved in its biosynthesis, increase membrane fluidity, leading to increased cell stiffness, impair extracellular matrix-mediated oncogenic signaling, and reduce ferroptosis resistance in breast cancer, and UBIAD1 is needed to limit circulating tumor cell survival and lung metastasis formation [6]. It is important to consider that these complex growth mechanisms are based on the metabolic redox regulation pathways in which cells acquire and utilize electron carriers to maintain directional carbon flux, sustain reductive biosynthesis, and support antioxidant defense, as recently considered [7].
CoQ10 is also in plasma membranes and cholesterol particles in plasma, providing antioxidant protection [8]. Plasma membranes contain a trans-membrane redox system that maintains both vitamins E and C in its reduced state, via CoQ10 reduction, through the membrane-bound NADH-cytochrome b5 reductase 3 (CYB5R3) and NAD(P)H: quinone oxidoreductase 1 (NQO1). This system prevents ceramide-mediated apoptosis [9]. The overexpression of this system was observed to increase the life- and health-span of mice, modulating lipid metabolism and improving respiration [10].
Additionally, ferroptosis is prevented by the ferroptosis suppressor protein 1 (FSP1)/apoptosis-inducing factor mitochondria-associated 2 (AIFM2) reduction of CoQ10 in plasma membranes, acting in parallel with glutathione-dependent lipid hydroperoxidase glutathione peroxidase 4 (GPX4) [11,12].
In eukaryotes, the CoQ10 biosynthesis pathway is carried out by proteins encoded by nuclear COQ genes that interact, generating a CoQ10 biosynthesis complex known as CoQ synthome [13]. However, not all enzyme reactions and the regulation of CoQ synthome have been clarified [14]. This year, the function of COQ4 in the decarboxylation and hydroxylation reactions of carbon in position 1 was demonstrated [15]. New advances in CoQ biosynthesis introduced the recently discovered protein RTN4IP1/OPA10 as a mitochondrial component required in this pathway, increasing its complexity and regulation [16]. New advances in CoQ biosynthesis research have provided insights into the molecular mechanisms of this complex pathway through the in vitro construction of the animal CoQ biosynthesis metabolon [17] and the reconstruction of E. coli Ubi metabolon [18].
Defects in CoQ synthome components or its regulatory elements lead to primary CoQ10 deficiencies, inducing highly heterogeneous clinical phenotypes and thus creating difficulties in establishing genotype–phenotype correlations; these deficiencies manifest as defects in the skeletal muscle, central and peripheral nervous systems, kidney, and heart. These are rare autosomal recessive conditions characterized by reduced levels of CoQ10 in tissues and organs [19].
All these topics were presented and discussed at the 10th Conference of the International Coenzyme Q10 Association that took place from 12 to 15 May 2022 in Hamburg, Germany. For the first time, the conference was hosted in collaboration with an industrial partner, Beiersdorf, highlighting the growing importance of applied research in this field. This partnership underscored the significance of bridging the gap between academic research and real-world industrial applications, and it provided a fertile ground for the research presented here.
As we draw this Special Issue of Antioxidants to a close (https://www.mdpi.com/journal/antioxidants/special_issues/Antioxidants_Coenzyme) (accessed 17 October 2024), we reflect on the outstanding research contributions presented and discussed at this conference, highlighting the multifaceted roles of CoQ10. This Special Issue has garnered six significant contributions that delve into the multifaceted roles of CoQ10, emphasizing its biological importance, therapeutic potential, and the challenges associated with its deficiency. Across these studies, CoQ10 emerges as a vital molecule, not only for its well-known antioxidant properties but also for its crucial role in cellular energy production, bioenergetics, and metabolic regulation.
One key focus of this Special Issue, encapsulated by one study, is the cellular uptake and distribution of CoQ10, demonstrated through innovative techniques like X-ray fluorescence (XRF) imaging. This study provides valuable insights into how CoQ10 is absorbed by skin cells, laying the groundwork for its potential use in anti-aging and oxidative stress protection therapies. Another study explores the role of CoQ10 in brown adipose tissue (BAT), highlighting its regulatory effect on thermogenesis through the expression of uncoupling protein 1 (UCP1). The findings suggest that CoQ10 deficiencies can impair energy metabolism and contribute to metabolic disorders such as obesity, pointing to its therapeutic relevance in these conditions. CoQ deficiency in BAT results in the activation of the integrated stress response with a suppression of UCP1 but an induction of FGF21 expression. A BAT-specific CoQ deficiency interacts with inguinal white adipose tissue (iWAT), causing an increase in the browning of iWAT in deficient animals [20].
In this context, long-term CoQ10 supplementation lowered lipid peroxidation particles, conferring health benefits by decreasing cardiovascular mortality and improving the functional classification class of the New York Heart Association (NYHA) [21,22]. Selenium associated with CoQ10 supplementation also activated selenoprotein P, providing benefits to inflammation, the length of telomeres, quality of life, and mortality [23]. This is partially explained by the regulation of vascular flexibility due to the mitigation of endothelial inflammatory activation caused by CYB5R3, assisting in NOX4-dependent H2O2 generation via CoQ10 [24].
As indicated above, CoQ10 supplementation was proposed as a therapy to improve the health of people suffering from various disorders such as inflammation, metabolic syndrome, and male infertility, among others [25]. A trial focused on CoQ10 supplementation demonstrated an improvement of liver steatosis and endothelial, vascular and myocardial function in patients with metabolic dysfunction-associated steatotic liver disease [26].
Furthermore, a comprehensive review of CoQ10 biosynthesis and deficiencies underscores the diagnostic challenges and therapeutic gaps in addressing both primary and secondary CoQ10 deficiencies. Secondary CoQ10 deficiencies are particularly challenging because they are caused by mutations in genes that are not involved in CoQ synthome or its regulation. These diseases do not respond to CoQ10 supplementation, meaning that new personalized therapies should be developed [27]. The need for improved supplementation strategies and better drug delivery methods is highlighted, particularly for crossing the blood–brain barrier. Complementing this, an AlphaFold structural analysis of the COQ2 enzyme, central to CoQ10 biosynthesis, sheds light on how mutations disrupt CoQ10 production, leading to primary CoQ10 deficiencies. Together, these studies offer a cohesive and detailed exploration of CoQ10, reinforcing its critical role in health and advancing the conversation on how to better harness its therapeutic potential. According to these contributions, it should be emphasized that as CoQ10 supplementation is the treatment for primary CoQ10 deficiencies, its bioavailability should be the focus of current and future translational research, including recent attempts made to develop new formulations and use CoQ synthome intermediates for personalized therapies [28,29,30].
To further understand the lack of positive response to CoQ10 supplementation in secondary CoQ10 deficiencies, it is important to consider that most patients suffering from these diseases show symptoms in the perinatal stage, which indicates that the pathomechanisms are established during their development [31]. Pertaining to this, prenatal treatment with CoQ10 in a mouse model of secondary CoQ deficiency demonstrated a higher benefit than the treatment of the adult animal, indicating that providing CoQ10 supplementation to pregnant mothers should be recommended [32].
This Special Issue also addresses the broader role of mitochondrial reactive oxygen species (mtROS) in the aging population, illustrating how disruptions in redox signaling can lead to age-related diseases. This review suggests a shift from traditional antioxidant approaches to therapies that restore balanced redox signaling. In the same vein, the enhanced bioavailability of CoQ10 through phytosome-based formulations like ubiqsome is explored, offering promising advancements in CoQ10 delivery, especially in muscle cells, where its uptake is typically limited.
Looking ahead, the 11th Conference of the International CoQ10 Association will be hosted by the University of Copenhagen from 16 to 19 June 2025 (https://icq10a.com/). This upcoming event promises to build on the strong foundation laid by previous conferences, offering new opportunities to engage with cutting-edge research on CoQ10. We are pleased to announce that this year’s conference will include, for the first time, an educational day on June 16. This pre-conference event is designed to bring CoQ10 science to a younger audience, with activities tailored for college undergraduates and recent graduates in biomedical disciplines or medicine. It will offer an informative introduction to CoQ10 research while encouraging curiosity and providing guidance on potential career paths in this rapidly evolving field.
Key topics of the upcoming conference will include new advances in CoQ10 biosynthesis, the use of precursors to increase CoQ10 production, primary and secondary CoQ10 deficiencies, and clinical applications in areas such as cognitive health, persistent COVID, cardiovascular disease, and heart failure. In addition, sessions will cover the bioavailability of CoQ and its role in sport, physical activity, and healthy aging.
We hope this Special Issue serves as both a reference point and an inspiration for ongoing and future research into CoQ10. We extend our heartfelt thanks to all contributing authors for their exceptional work and to the reviewers for their invaluable feedback. We would also like to express our gratitude to the editorial team of Antioxidants for their support throughout this process. Together, we have curated a collection of papers that not only advances the science of CoQ10 but also stimulates the development of new research perspectives and future collaborations.
We invite all our readers and contributors to join us in Copenhagen, June 2025, where we will continue to explore and expand the boundaries of CoQ10 research.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Acin-Perez, R.; Enriquez, J.A. The function of the respiratory supercomplexes: The plasticity model. Biochim. Biophys. Acta 2014, 1837, 444–450. [Google Scholar] [CrossRef]
  2. Cogliati, S.; Cabrera-Alarcon, J.L.; Enriquez, J.A. Regulation and functional role of the electron transport chain supercomplexes. Biochem. Soc. Trans. 2021, 49, 2655–2668. [Google Scholar] [CrossRef]
  3. Herrero Martin, J.C.; Salegi Ansa, B.; Alvarez-Rivera, G.; Dominguez-Zorita, S.; Rodriguez-Pombo, P.; Perez, B.; Calvo, E.; Paradela, A.; Miguez, D.G.; Cifuentes, A.; et al. An ETFDH-driven metabolon supports OXPHOS efficiency in skeletal muscle by regulating coenzyme Q homeostasis. Nat. Metab. 2024, 6, 209–225. [Google Scholar] [CrossRef]
  4. Banerjee, R.; Purhonen, J.; Kallijärvi, J. The mitochondrial coenzyme Q junction and complex III: Biochemistry and pathophysiology. FEBS J. 2021, 289, 6936–6958. [Google Scholar] [CrossRef]
  5. Martínez-Reyes, I.; Cardona, L.R.; Kong, H.; Vasan, K.; McElroy, G.S.; Werner, M.; Kihshen, H.; Reczek, C.R.; Weinberg, S.E.; Gao, P.; et al. Mitochondrial ubiquinol oxidation is necessary for tumour growth. Nature 2020, 7824, 288–292. [Google Scholar] [CrossRef]
  6. Tosi, G.; Paoli, A.; Zuccolotto, G.; Turco, E.; Simonato, M.; Tosoni, D.; Tucci, F.; Lugato, P.; Giomo, M.; Elvassore, N.; et al. Cancer cell stiffening via CoQ(10) and UBIAD1 regulates ECM signaling and ferroptosis in breast cancer. Nat. Commun. 2024, 15, 8214. [Google Scholar] [CrossRef]
  7. Zhen, Z.; Ren, J.; Zhu, J. The redox requirement and regulation during cell proliferation. Trends Endocrinol. Metab. 2024, 35, 385–399. [Google Scholar] [CrossRef]
  8. Lopez-Lluch, G.; Rodriguez-Aguilera, J.C.; Santos-Ocana, C.; Navas, P. Is coenzyme Q a key factor in aging? Mech. Ageing Dev. 2010, 131, 225–235. [Google Scholar] [CrossRef]
  9. Kagan, V.E.; Straub, A.C.; Tyurina, Y.Y.; Kapralov, A.A.; Hall, R.; Wenzel, S.E.; Mallampalli, R.K.; Bayir, H. Vitamin E/Coenzyme Q-Dependent “Free Radical Reductases”: Redox Regulators in Ferroptosis. Antioxid. Redox Signal 2024, 40, 317–328. [Google Scholar] [CrossRef]
  10. Diaz-Ruiz, A.; Lanasa, M.; Garcia, J.; Mora, H.; Fan, F.; Martin-Montalvo, A.; Di Francesco, A.; Calvo-Rubio, M.; Salvador-Pascual, A.; Aon, M.A.; et al. Overexpression of CYB5R3 and NQO1, two NAD. Aging Cell 2018, 17, e12767. [Google Scholar] [CrossRef]
  11. Berndt, C.; Alborzinia, H.; Amen, V.S.; Ayton, S.; Barayeu, U.; Bartelt, A.; Bayir, H.; Bebber, C.M.; Birsoy, K.; Bottcher, J.P.; et al. Ferroptosis in health and disease. Redox Biol. 2024, 75, 103211. [Google Scholar] [CrossRef]
  12. Dixon, S.J.; Olzmann, J.A. The cell biology of ferroptosis. Nat. Rev. Mol. Cell Biol. 2024, 25, 424–442. [Google Scholar] [CrossRef]
  13. Stefely, J.A.; Pagliarini, D.J. Biochemistry of Mitochondrial Coenzyme Q Biosynthesis. Trends Biochem. Sci. 2017, 42, 824–843. [Google Scholar] [CrossRef]
  14. Villalba, J.M.; Navas, P. Regulation of coenzyme Q biosynthesis pathway in eukaryotes. Free Radic. Biol. Med. 2021, 165, 312–323. [Google Scholar] [CrossRef]
  15. Pelosi, L.; Morbiato, L.; Burgardt, A.; Tonello, F.; Bartlett, A.K.; Guerra, R.M.; Ferizhendi, K.K.; Desbats, M.A.; Rascalou, B.; Marchi, M.; et al. COQ4 is required for the oxidative decarboxylation of the C1 carbon of coenzyme Q in eukaryotic cells. Mol. Cell 2024, 84, 981–989.e7. [Google Scholar] [CrossRef]
  16. Park, I.; Kim, K.E.; Kim, J.; Kim, A.K.; Bae, S.; Jung, M.; Choi, J.; Mishra, P.K.; Kim, T.M.; Kwak, C.; et al. Mitochondrial matrix RTN4IP1/OPA10 is an oxidoreductase for coenzyme Q synthesis. Nat. Chem. Biol. 2024, 20, 221–233. [Google Scholar] [CrossRef]
  17. Nicoll, C.R.; Alvigini, L.; Gottinger, A.; Cecchini, D.; Mannucci, B.; Corana, F.; Mascotti, M.L.; Mattevi, A. In vitro construction of the COQ metabolon unveils the molecular determinants of coenzyme Q biosynthesis. Nat. Catal. 2024, 7, 148–160. [Google Scholar] [CrossRef]
  18. Launay, R.; Chobert, S.C.; Abby, S.S.; Pierrel, F.; Andre, I.; Esque, J. Structural Reconstruction of E. coli Ubi Metabolon Using an AlphaFold2-Based Computational Framework. J. Chem. Inf. Model. 2024, 64, 5175–5193. [Google Scholar] [CrossRef]
  19. Alcázar-Fabra, M.; Rodríguez-Sánchez, F.; Trevisson, E.; Brea-Calvo, G. Primary Coenzyme Q deficiencies: A literature review and online platform of clinical features to uncover genotype-phenotype correlations. Free Radic. Biol. Med. 2021, 167, 141–180. [Google Scholar] [CrossRef]
  20. Chang, C.F.; Gunawan, A.L.; Liparulo, I.; Zushin, P.H.; Vitangcol, K.; Timblin, G.A.; Saijo, K.; Wang, B.; Parlakgul, G.; Arruda, A.P.; et al. Brown adipose tissue CoQ deficiency activates the integrated stress response and FGF21-dependent mitohormesis. EMBO J. 2024, 43, 168–195. [Google Scholar] [CrossRef]
  21. Mortensen, S.A.; Rosenfeldt, F.; Kumar, A.; Dolliner, P.; Filipiak, K.J.; Pella, D.; Alehagen, U.; Steurer, G.; Littarru, G.P.; Investigators, Q.S.S. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: Results from Q-SYMBIO: A randomized double-blind trial. JACC Heart Fail. 2014, 2, 641–649. [Google Scholar] [CrossRef]
  22. Alehagen, U.; Alexander, J.; Aaseth, J. Supplementation with Selenium and Coenzyme Q10 Reduces Cardiovascular Mortality in Elderly with Low Selenium Status. A Secondary Analysis of a Randomised Clinical Trial. PLoS ONE 2016, 11, e0157541. [Google Scholar] [CrossRef]
  23. Alehagen, U.; Aaseth, J.; Schomburg, L.; Larsson, A.; Opstad, T.; Alexander, J. Selenoprotein P increases upon selenium and coenzyme Q(10) supplementation and is associated with telomere length, quality of life and reduced inflammation and mortality. Free Radic. Biol. Med. 2024, 222, 403–413. [Google Scholar] [CrossRef]
  24. Yuan, S.; Hahn, S.A.; Miller, M.P.; Sanker, S.; Calderon, M.J.; Sullivan, M.; Dosunmu-Ogunbi, A.M.; Fazzari, M.; Li, Y.; Reynolds, M.; et al. Cooperation between CYB5R3 and NOX4 via coenzyme Q mitigates endothelial inflammation. Redox Biol. 2021, 47, 102166. [Google Scholar] [CrossRef]
  25. Gasmi, A.; Bjorklund, G.; Mujawdiya, P.K.; Semenova, Y.; Piscopo, S.; Peana, M. Coenzyme Q(10) in aging and disease. Crit. Rev. Food Sci. Nutr. 2024, 64, 3907–3919. [Google Scholar] [CrossRef]
  26. Vrentzos, E.; Ikonomidis, I.; Pavlidis, G.; Katogiannis, K.; Korakas, E.; Kountouri, A.; Pliouta, L.; Michalopoulou, E.; Pelekanou, E.; Boumpas, D.; et al. Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: A randomized double-blind, placebo-controlled trial. Cardiovasc. Diabetol. 2024, 23, 245. [Google Scholar] [CrossRef]
  27. Navas, P.; Cascajo, M.V.; Alcázar-Fabra, M.; Hernández-Camacho, J.D.; Sánchez-Cuesta, A.; Rodríguez, A.B.C.; Ballesteros-Simarro, M.; Arroyo-Luque, A.; Rodríguez-Aguilera, J.C.; Fernández-Ayala, D.J.M.; et al. Secondary CoQ. Biofactors 2021, 47, 551–569. [Google Scholar] [CrossRef]
  28. Bhagavan, H.N.; Chopra, R.K. Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic. Res. 2006, 40, 445–453. [Google Scholar] [CrossRef]
  29. Pesini, A.; Hidalgo-Gutierrez, A.; Quinzii, C.M. Mechanisms and Therapeutic Effects of Benzoquinone Ring Analogs in Primary CoQ Deficiencies. Antioxidants 2022, 11, 665. [Google Scholar] [CrossRef]
  30. Corral-Sarasa, J.; Martinez-Galvez, J.M.; Gonzalez-Garcia, P.; Wendling, O.; Jimenez-Sanchez, L.; Lopez-Herrador, S.; Quinzii, C.M.; Diaz-Casado, M.E.; Lopez, L.C. 4-Hydroxybenzoic acid rescues multisystemic disease and perinatal lethality in a mouse model of mitochondrial disease. Cell Rep. 2024, 43, 114148. [Google Scholar] [CrossRef]
  31. Waldvogel, S.M.; Posey, J.E.; Goodell, M.A. Human embryonic genetic mosaicism and its effects on development and disease. Nat. Rev. Genet. 2024, 25, 698–714. [Google Scholar] [CrossRef]
  32. Hernandez-Camacho, J.D.; Vicente-Garcia, C.; Ardila-Garcia, L.; Padilla-Campos, A.; Lopez-Lluch, G.; Santos-Ocana, C.; Zammit, P.S.; Carvajal, J.J.; Navas, P.; Fernandez-Ayala, D.J.M. Prenatal and progressive coenzyme Q(10) administration to mitigate muscle dysfunction in mitochondrial disease. J. Cachexia Sarcopenia Muscle 2024. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Tiano, L.; Navas, P. The Ubiquitous and Multifaceted Coenzyme Q. Antioxidants 2024, 13, 1261. https://doi.org/10.3390/antiox13101261

AMA Style

Tiano L, Navas P. The Ubiquitous and Multifaceted Coenzyme Q. Antioxidants. 2024; 13(10):1261. https://doi.org/10.3390/antiox13101261

Chicago/Turabian Style

Tiano, Luca, and Plácido Navas. 2024. "The Ubiquitous and Multifaceted Coenzyme Q" Antioxidants 13, no. 10: 1261. https://doi.org/10.3390/antiox13101261

APA Style

Tiano, L., & Navas, P. (2024). The Ubiquitous and Multifaceted Coenzyme Q. Antioxidants, 13(10), 1261. https://doi.org/10.3390/antiox13101261

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop